Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey

Tara Nazareth1, Jackie Polyakov1, Ed Banfe1, Kristine Zerkowski2, Leslie Beth Herbert2

Underestimation of relapse in multiple sclerosis (MS) is detrimental to the patient as well as to their relationship with their MS healthcare professional (HCP). To obtain direct insight into relapse prevalence, symptoms, and HCP engagement from patients with MS who responded to the MS in America (MSIA) 2017 survey.

Read more about the accepted manuscript here.

Read more about the accepted abstract here.

1Mallinckrodt Pharmaceuticals, external partner
2Health Union, LLC